Day: September 12, 2024

First presentation of detailed Phase 2 results following previous positive topline announcement that study of NTLA-2002 met primary and all secondary endpoints Intellia to host investor webcast on Monday, October 28, at 8:00 a.m. ETCAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that data from the Phase 2 study of NTLA-2002 will be presented at the 2024 American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, taking place October 24 – 28 in Boston, Massachusetts. NTLA-2002 is an investigational in vivo CRISPR-based gene editing therapy in development as a single-dose treatment for hereditary angioedema (HAE), a rare genetic...

Vancouver, BC, Sept. 12, 2024 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd.’s (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce the appointment of Serdar Donmez, a recognized geoscientist with decades of experience in uranium exploration and development, as Vice President of Exploration. Mr. Donmez will be working with the rest of Skyharbour’s geological team based in Saskatoon.As a highly experienced geoscientist with nearly two decades of expertise in uranium exploration and development, Mr. Donmez has played an active role in numerous grassroots and advanced uranium exploration projects in northern Saskatchewan and Zambia. Mr. Donmez has an Engineering Degree in Geology and is a registered Professional Geoscientist with the Association of Professional Engineers and Geoscientists of Saskatchewan.During...

TROY, Mich., Sept. 12, 2024 (GLOBE NEWSWIRE) — Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced that Troy R. Anderson has been named executive vice president and chief financial officer designate, effective October 14, 2024. Following an orderly transition of responsibilities, Anderson will succeed Olivier Thirot, executive vice president and chief financial officer, who on July 8, 2024, informed Kelly of his intention to retire as an officer of the Company. Upon completion of the transition, Thirot will serve as a strategic advisor to the Company. “I am pleased to welcome Troy to Kelly as the Company’s next chief financial officer. His experience successfully executing business transformations, track record of accelerating profitable growth, and passion for developing and leading...

Participants Collectively Employ over 30,000 Across 41 States in Home Care, Hospice and Skilled Nursing. Company Estimates App Will Dramatically Reduce Costs and Improve Patient Care DETROIT, Sept. 12, 2024 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today the launch of pilot programs in five (5) home health agencies and skilled nursing facilities across the U.S. Collectively, these companies and their franchisees have over 30,000 employees, ranging in professions from clinical officers, CMPs, CNSs, NPs, RNs, Pediatric RNs, PTs, OTs, LVNs/LPNs, CNAs, NAs, Home Care Nurses, HHAs and caregivers. NurseMagic™’s five pilot customers provide skilled nursing, hospice care services and home healthcare....

WASHINGTON, Sept. 12, 2024 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Jeff Wray as a Senior Managing Director and Industry Growth and Strategy Leader within the Corporate Finance & Restructuring segment. Mr. Wray will focus on building industry teams across the firm’s strategy, transformation and transactions capabilities and will lead the new Consumer & Retail industry practice within FTI Delta, the strategy consulting practice of FTI Consulting. Mr. Wray, who is based in Philadelphia and New York, brings more than 20 years of strategy and consulting experience to his new role, including expertise in personal care, consumer electronics, apparel and retail. He joins FTI Delta from EY-Parthenon, where he served as Global EY-Parthenon Leader. At FTI Delta, Mr. Wray will work closely...

SAN MATEO, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced that an oral presentation highlighting denifanstat’s anti-fibrotic activity in metabolic dysfunction-associated steatohepatitis (MASH) will be given at the 8th Annual MASH Drug Development Summit being held in Boston on September 24-26, 2024. MASH Drug Development Summit Presentation Details: Presentation Title: Demonstrating denifanstat’s differentiated approach in MASH with mechanistic and clinical data showing direct anti-fibrotic activityPresenter: Marie O’Farrell, Ph.D., Senior Vice President of Research and Development, Sagimet BiosciencesSession:...

TEL AVIV, Israel, Sept. 12, 2024 (GLOBE NEWSWIRE) — Gauzy Ltd. (Nasdaq: GAUZ) (“Gauzy” or the “Company”), a global leader in vision and light control solutions, today announced Eyal Peso, Co-Founder and Chief Executive Officer; Adrian Lofer, Co-Founder and Chief Technology Officer; Meir Peleg, Chief Financial Officer; and pre-IPO Gauzy Board member and long-term investor Alejandro Weinstein have acquired an aggregate of 48,472 Gauzy ordinary shares. The purchases, made at an average price of $10.35/share, for a total investment of $501,400, were made through open market purchases during the months of August and September 2024. “This investment by core current and former leaders of Gauzy underscores our unwavering commitment and belief in our company’s vision and potential,” Mr. Peso stated. “Our strong orderbook, pipeline of exciting...

Closes $150 million 5-year credit facility at an industry-leading interest rate of SOFR +5.00% Utilizes proceeds to retire existing senior secured debt, due April 30, 2025 Oversubscribed, non-brokered offering is a first-of-its-kind of bank-only financing in the U.S. cannabis industryCHICAGO and VANCOUVER, British Columbia, Sept. 12, 2024 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it has closed on a $150 million 5-year syndicated credit facility led by Valley National Bank, a regional bank with over $62 billion in assets and the principal subsidiary of Valley National Bancorp. The Company intends to use the proceeds along with existing cash to retire its...

Presentation on Tuesday, September 17th, at 11:00 a.m. E.T. BOULDER, CO, Sept. 12, 2024 (GLOBE NEWSWIRE) — Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) (“Auddia” or the “Company”), a proprietary AI platform for audio identification and classification and related technologies, reinventing how consumers engage with AM/FM radio, podcasts, and other audio content, today announced that Executive Chairman Jeff Thramann has been invited to present at the 2024 Gaming, Media & Entertainment Virtual Conference, presented by Maxim Group LLC, on Tuesday, September 17th, 2024, at 11:00 a.m. E.T. As the Gaming, Media & Entertainment industries continue to evolve, companies are navigating shifting consumer demand and global challenges. The conference will explore how emerging growth companies are adapting to the current market environment...

Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisions Progressing with proven path toward standard of care addressing chronic low back pain, the largest expenditure in US healthcare costing Americans an estimated $134 Billion annually More than $50 Million has been invested in the promising Aclarion AI platform that aids physicians in identification of painful discs Technology protected by 23 issued US patents, 17 issued international patents, and 12 pending patent applications Three of four largest private insurance payers in the UK now covering Nociscan Partnership with ten prominent KOL surgeons signed on to assist Aclarion in successfully gaining traction and reimbursement throughout the United States BROOMFIELD, CO, Sept. 12, 2024 (GLOBE NEWSWIRE) —...